comparemela.com

Latest Breaking News On - Revolutionizing atopic dermatitis - Page 1 : comparemela.com

Dupilumab Versus Lebrikizumab with Topical Corticosteroids: Efficacy in Atopic Dermatitis

These data highlighted which drug, in combination with topical corticosteroids, produced the best efficacy results for those with atopic dermatitis.

United statesPatricia guyotAtopic dermatitisGlobal assessmentEczema areaSeverity indexNumerical rating scaleDermatology life quality indexRevolutionizing atopic dermatitis

Ruxolitinib Consistent in Safety, Tolerability Over 52-Weeks in Children with Extensive Atopic Dermatitis

Treating eczema twice-daily with ruxolitinib cream, 1.5% led to positive results for children in the age range of 2 to 11 years.

United statesRobert bissonnetteInnovaderm researchInnovaderm research robert bissonnetteRevolutionizing atopic dermatitisMaximum use trialGlobal assessmentTreatment successDermatology life quality indexPatient oriented eczema measureInfant dermatitis quality

LEVEL UP: Upadacitinib Bests Dupilumab for Moderate-to-Severe Atopic Dermatitis

LEVEL UP data presented at RAD 2024 provide additional insight into the phase 3b/4 trial comparing upadacitinib and dupilumab in atopic dermatitis beyond the primary endpoint.

United statesJonathan silverbergHealth scienceDrug administrationGeorge washington university school of medicineAbbvie news centerGeorge washington university jonathan silverbergOffice of the commissionerGeorge washington universityRevolutionizing atopic dermatitisGeorge washington university schoolEczema areaSeverity indexWorst pruritus numerical rating scaleModerate to severe atopic dermatitisEfficacy assessor blinded head to phase

Eczema Patients Treated with Upadacitinib in Real World Setting See Significant Improvements

This late-breaking data featured at RAD 2024 highlights several improvements in patient reported outcomes observed among atopic dermatitis patients, including itch relief.

United statesJonathan silverbergDrug administrationGeorge washington university school of medicineHealth sciencesRevolutionizing atopic dermatitisClinically relevant patient reported outcomesLong term effectivenessAtopic dermatitisGeorge washington university

How to Manage Atopic Comorbidities Among Atopic Dermatitis Patients, with Anne Marie Singh, MD

In her presentation at RAD 2024, Singh highlighted ways to manage the atopic comorbidities linked to eczema in children.

United statesMadison schoolTim smithAnne marie singhUniversity of wisconsinPublic healthMadison school of medicineMarie singhRevolutionizing atopic dermatitis

vimarsana © 2020. All Rights Reserved.